Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

This study investigated the long-term antihypertensive effects of esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, alone or in combination with a calcium channel blocker (CCB) or a renin–angiotensin system (RAS) inhibitor, in Japanese patients with essential hypertension. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakugi, Hiromi, Ito, Sadayoshi, Itoh, Hiroshi, Okuda, Yasuyuki, Yamakawa, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076031/
https://www.ncbi.nlm.nih.gov/pubmed/31554937
http://dx.doi.org/10.1038/s41440-019-0314-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076031/
https://www.ncbi.nlm.nih.gov/pubmed/31554937
http://dx.doi.org/10.1038/s41440-019-0314-7

Ejemplares similares